All Stories

  1. Hijacking exosome biogenesis: viral glycoproteins as modular scaffolds for engineering functionalized extracellular vesicles
  2. Fetal pHocus: A Novel Approach to Non-Invasive Fetal Arterial Blood pHAssessment via Near-Infrared Spectroscopy
  3. Targeting peptide homes to spinal cord injury in a rat model
  4. Designing Programmable Peptide Nucleic Acid‐based Nanovaccines for Anticancer Immune Activation
  5. Bilateral carotid‐jugular arteriovenous graft implantation in an ovine model is safe and durable for facilitation of arteriovenous graft innovation
  6. Hybrid Extracellular Vesicles With Combined Functional Properties From Mesenchymal Stem Cells and Astrocytes for Targeted Neurodegenerative Disease Applications
  7. Alternating 2D and 3D culture reduces cell size and extends the lifespan of placenta-derived mesenchymal stem cells
  8. Alternating 2D and 3D Culture Reduces Cell Size and Extends the Lifespan of Placenta-Derived MSCs
  9. Designer artificial environments for membrane protein synthesis
  10. Control of Physical and Biochemical Parameters Influencing Exogeneous Cargo Protein Association to Extracellular Vesicles Using Lipid Anchors Enables High Loading and Effective Intracellular Delivery
  11. Human skeletal development and regeneration are shaped by functional diversity of stem cells across skeletal sites
  12. Prosthesis Embodiment in Lower Extremity Limb Loss: A Narrative Review
  13. Collagen Nanofiber Reinforced Alginate Hydrogel Tube Microbioreactors for Cell Culture
  14. Scalable Culture of Mammalian Cells in RGD Peptide-Modified Alginate Hydrogel Microtubes
  15. Non-invasive detection of instantaneous fetal hypoxemia in large animal model of pregnancy
  16. Extracellular matrix ligands modulate the endothelial progenitor cell secretome for enhanced angiogenesis
  17. Validation of a Precise Impactor in a Rodent Cervical Spinal Cord Injury Hemi-Contusion Model
  18. Perinatal Caffeine Administration Improves Outcomes in an Ovine Model of Neonatal Hypoxia-Ischemia
  19. Harnessing extracellular vesicle heterogeneity for diagnostic and therapeutic applications
  20. Widespread Gene Editing in the Brain via In Utero Delivery of mRNA Using Acid-Degradable Lipid Nanoparticles
  21. Systematic Review of Peptide CAQK: Properties, Applications, and Outcomes
  22. A critical systematic review of extracellular vesicle clinical trials
  23. Control of physical and biochemical parameters influencing exogeneous cargo protein association to extracellular vesicles using lipid anchors enables high loading and effective intracellular delivery
  24. Acid-degradable lipid nanoparticles enhance the delivery of mRNA
  25. Fabrication of cyborg bacterial cells as living cell–material hybrids using intracellular hydrogelation
  26. Bioinformatics Copilot 2.0 for Transcriptomic Data Analysis
  27. The Role of Biophysical Factors in Organ Development: Insights from Current Organoid Models
  28. TransMetaSegmentation (TMS): a transcriptome-based segmentation method for spatial metabolomic data
  29. Approaches to Characterize and Quantify Extracellular Vesicle Surface Conjugation Efficiency
  30. Bioinformatics Copilot 1.0: A Large Language Model-powered Software for the Analysis of Transcriptomic Data
  31. Development of pro‐angiogenic skin substitutes for wound healing
  32. Assessing the conjugation efficiency of surface-modified extracellular vesicles using single nanovesicle analysis technologies
  33. Perinatal Azithromycin Provides Limited Neuroprotection in an Ovine Model of Neonatal Hypoxic-Ischemic Encephalopathy
  34. Recovering fetal signals transabdominally through interferometric near-infrared spectroscopy (iNIRS)
  35. Sample Preparation Method for MALDI Mass Spectrometry Imaging of Fresh-Frozen Spines
  36. Effect of Clemastine on Neurophysiological Outcomes in an Ovine Model of Neonatal Hypoxic-Ischemic Encephalopathy
  37. Chitosan hydrogels with MK2 inhibitor peptide-loaded nanoparticles to treat atopic dermatitis
  38. A bio-instructive parylene-based conformal coating suppresses thrombosis and intimal hyperplasia of implantable vascular devices
  39. Spatial lipidomics of fresh-frozen spines
  40. In utero delivery of mRNA to the heart, diaphragm and muscle with lipid nanoparticles
  41. Protocol for vision transformer-based evaluation of drug potency using images processed by an optimized Sobel operator
  42. Evaluation of a biodegradable polyurethane patch for repair of diaphragmatic hernia in a rat model: A pilot study
  43. Bioengineering approaches for nerve graft revascularization: Current concepts and future directions
  44. Engineered multi-functional, pro-angiogenic collagen-based scaffolds loaded with endothelial cells promote large deep burn wound healing
  45. Molecular Basis of Surgical Coaptation Techniques in Peripheral Nerve Injuries
  46. A bioactive material with dual integrin-targeting ligands regulates specific endogenous cell adhesion and promotes vascularized bone regeneration in adult and fetal bone defects
  47. SIC50: Determining drug inhibitory concentrations using a vision transformer and an optimized Sobel operator
  48. Role of MEF2C in the Endothelial Cells Derived from Human Induced Pluripotent Stem Cells
  49. Engineering Cyborg Bacteria Through Intracellular Hydrogelation
  50. Convergence of human and veterinary medicine: leveraging canine naturally occurring neurological disorders to develop regenerative treatments
  51. Evolution and Variations of the Ovine Model of Spina Bifida
  52. A bioactive compliant vascular graft modulates macrophage polarization and maintains patency with robust vascular remodeling
  53. Development and Characterization of Bioinspired Lipid Raft Nanovesicles for Therapeutic Applications
  54. Non-viral gene editingin uterowith lipid nanoparticles complexed to mRNA
  55. SIC50: Determination of IC50 by an optimized Sobel operator and a vision transformer
  56. Bioengineering Extracellular Vesicles for the Treatment of Cardiovascular Diseases
  57. Spina Bifida: A Review of the Genetics, Pathophysiology and Emerging Cellular Therapies
  58. Engineering Extracellular Microenvironment for Tissue Regeneration
  59. Early investigations into improving bowel and bladder function in fetal ovine myelomeningocele repair
  60. Impact of Gestational Age on Neuroprotective Function of Placenta-Derived Mesenchymal Stromal Cells
  61. Bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing
  62. Efficacy of clinical-grade human placental mesenchymal stromal cells in fetal ovine myelomeningocele repair
  63. Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion
  64. Genetic and Molecular Determinants of Lymphatic Malformations: Potential Targets for Therapy
  65. In Vitro, In Vivo and Ex Vivo Models for Peripheral Nerve Injury and Regeneration
  66. The Molecular Mechanisms Through Which Placental Mesenchymal Stem Cell‐Derived Extracellular Vesicles Promote Myelin Regeneration
  67. Engineered extracellular vesicles with high collagen-binding affinity present superior in situ retention and therapeutic efficacy in tissue repair
  68. Long-term safety evaluation of placental mesenchymal stromal cells for in utero repair of myelomeningocele in a novel ovine model
  69. Placental Mesenchymal Stromal Cells: Preclinical Safety Evaluation for Fetal Myelomeningocele Repair
  70. The Unique Properties of Placental Mesenchymal Stromal Cells: A Novel Source of Therapy for Congenital and Acquired Spinal Cord Injury
  71. Engineering extracellular vesicles for Alzheimer's disease: An emerging cell‐free approach for earlier diagnosis and treatment
  72. Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID‐19 Therapy
  73. Engineered neuron-targeting, placental mesenchymal stromal cell-derived extracellular vesicles for in utero treatment of myelomeningocele
  74. Fabrication and evaluation of an optimized xenogenic decellularized costal cartilage graft: preclinical studies of a novel biocompatible prosthesis for rhinoplasty
  75. Tetraspanins are unevenly distributed across single extracellular vesicles and bias sensitivity to multiplexed cancer biomarkers
  76. Towards Noninvasive Accurate Detection of Intrapartum Fetal Hypoxic Distress
  77. Exosomal microRNAs from mesenchymal stem/stromal cells: Biology and applications in neuroprotection
  78. Proangiogenic Collagen-Binding Glycan Therapeutic Promotes Endothelial Cell Angiogenesis
  79. Identification of differentially expressed proteins involved in fetal scarless wound healing using a rat model of cleft lip
  80. Tetraspanin immunocapture phenotypes extracellular vesicles according to biofluid source but may limit identification of multiplexed cancer biomarkers
  81. Neural crest-like stem cells for tissue regeneration
  82. Functionalized extracellular matrix scaffolds loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing
  83. Bioengineered extracellular vesicle-loaded bioscaffolds for therapeutic applications in regenerative medicine
  84. Preliminary Evaluation of a Novel Fetal Guinea Pig Myelomeningocele Model
  85. A Novel Model of Fetal Spinal Cord Exposure Allowing for Long-Term Postnatal Survival
  86. <p>A Dual Receptor Targeting- and BBB Penetrating- Peptide Functionalized Polyethyleneimine Nanocomplex for Secretory Endostatin Gene Delivery to Malignant Glioma</p>
  87. Editorial: Nanotechnology in Cardiovascular Regenerative Medicine
  88. Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells
  89. Developing an Injectable Nanofibrous Extracellular Matrix Hydrogel With an Integrin αvβ3 Ligand to Improve Endothelial Cell Survival, Engraftment and Vascularization
  90. Placenta-derived multipotent mesenchymal stromal cells: a promising potential cell-based therapy for canine inflammatory brain disease
  91. Acetylation-Dependent Deubiquitinase OTUD3 Controls MAVS Activation in Innate Antiviral Immunity
  92. Extracellular Matrix Mimicking Nanofibrous Scaffolds Modified With Mesenchymal Stem Cell-Derived Extracellular Vesicles for Improved Vascularization
  93. Identity and lineage fate of proteolipid protein 1 gene (Plp1)‐expressing cells in the embryonic murine spinal cord
  94. Rapid endothelialization of small diameter vascular grafts by a bioactive integrin-binding ligand specifically targeting endothelial progenitor cells and endothelial cells
  95. Glial type specific regulation of CNS angiogenesis by HIFα-activated different signaling pathways
  96. A Dual Role of Type I Interferons in Antitumor Immunity
  97. Endothelial cells derived from patients’ induced pluripotent stem cells for sustained factor VIII delivery and the treatment of hemophilia A
  98. The Influence of Electron Beam Sterilization on In Vivo Degradation of β-TCP/PCL of Different Composite Ratios for Bone Tissue Engineering
  99. Multi-scale cellular engineering: From molecules to organ-on-a-chip
  100. Clonal isolation of endothelial colony-forming cells from early gestation chorionic villi of human placenta for fetal tissue regeneration
  101. Fibrin Glue/Fibronectin/Heparin-Based Delivery System of BMP2 Induces Osteogenesis in MC3T3-E1 Cells and Bone Formation in Rat Calvarial Critical-Sized Defects
  102. Glial type specific regulation of CNS angiogenesis by HIFα-activated different signaling pathways
  103. Engineering mesenchymal stromal/stem cell-derived extracellular vesicles with improved targeting and therapeutic efficiency for the treatment of central nervous system disorders
  104. Surviving Lambs with Myelomeningocele Repaired in utero with Placental Mesenchymal Stromal Cells for 6 Months: A Pilot Study
  105. A Decade of Experience with the Ovine Model of Myelomeningocele: Risk Factors for Fetal Loss
  106. Surface modification of polymeric electrospun scaffoldsviaa potent and high-affinity integrin α4β1 ligand improved the adhesion, spreading and survival of human chorionic villus-derived mesenchymal stem cells: a new insight for fetal tissue engi...
  107. Engineering Extracellular Vesicles as Nanotherapeutics for Regenerative Medicine
  108. Development of Injectable Amniotic Membrane Matrix for Postmyocardial Infarction Tissue Repair
  109. Placental Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Myelin Regeneration in an Animal Model of Multiple Sclerosis
  110. Hypoxic Preconditioning Enhances Survival and Proangiogenic Capacity of Human First Trimester Chorionic Villus-Derived Mesenchymal Stem Cells for Fetal Tissue Engineering
  111. Long Noncoding RNA-dependent Regulation of Vascular Smooth Muscle Cell Proliferation and Migration in Hypertension
  112. In Utero Treatment of Myelomeningocele with Placental Mesenchymal Stromal Cells — Selection of an Optimal Cell Line in Preparation for Clinical Trials
  113. Developing Regenerative Treatments for Developmental Defects, Injuries, and Diseases Using Extracellular Matrix Collagen-Targeting Peptides
  114. LncRNA TUG1 regulates FGF1 to enhance endothelial differentiation of adipose‐derived stem cells by sponging miR‐143
  115. Studies on the treatment of melanoma with folate acid conjugated dextran and lauryl alcohol loaded with IMD0354
  116. Neuroprotective effect of placenta-derived mesenchymal stromal cells: role of exosomes
  117. Spinal Angulation: A Limitation of the Fetal Lamb Model of Myelomeningocele
  118. Auricle shaping using 3D printing and autologous diced cartilage
  119. Overexpression of long non‐coding RNA NORAD promotes invasion and migration in malignant melanoma via regulating the MIR‐205‐EGLN2 pathway
  120. Blockage of transferred exosome‐shuttled miR‐494 inhibits melanoma growth and metastasis
  121. Potential long-term treatment of hemophilia A by neonatal co-transplantation of cord blood-derived endothelial colony-forming cells and placental mesenchymal stromal cells
  122. ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma
  123. Stem cell-based in utero therapies for spina bifida: implications for neural regeneration
  124. OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ
  125. High density placental mesenchymal stromal cells provide neuronal preservation and improve motor function following in utero treatment of ovine myelomeningocele
  126. Article Effect and Mechanism of Ganoderma lucidum Polysaccharides on Human Fibroblasts and Skin Wound Healing in Mice
  127. Matrix stiffness modulates the differentiation of neural crest stem cells in vivo
  128. The Stem Cell Factor Sox2 Is a Positive Timer of Oligodendrocyte Development in the Postnatal Murine Spinal Cord
  129. Human amnion extracellular matrix derived bioactive hydrogel for cell delivery and tissue engineering
  130. Differentially expressed circRNAs in melanocytes and melanoma cells and their effect on cell proliferation and invasion
  131. Sox2 Is Essential for Oligodendroglial Proliferation and Differentiation during Postnatal Brain Myelination and CNS Remyelination
  132. In Utero Transplantation of Placenta-Derived Mesenchymal Stromal Cells for Potential Fetal Treatment of Hemophilia A
  133. Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy
  134. Adult Stem Cells in Vascular Remodeling
  135. Fetal surgical repair with placenta-derived mesenchymal stromal cell engineered patch in a rodent model of myelomeningocele
  136. Placental mesenchymal stromal cells seeded on clinical grade extracellular matrix improve ambulation in ovine myelomeningocele
  137. Paxillin facilitates timely neurite initiation on soft-substrate environments by interacting with the endocytic machinery
  138. The Differentiation Stage of Transplanted Stem Cells Modulates Nerve Regeneration
  139. Isolation of myogenic progenitor cell population from human placenta: A pilot study
  140. Effect of 2-octylcyanoacrylate on placenta derived mesenchymal stromal cells on extracellular matrix
  141. Potential clinical applications of placental stem cells for use in fetal therapy of birth defects
  142. Sox10 + Cells Contribute to Vascular Development in Multiple Organs—Brief Report
  143. Viability and Biomechanics of Diced Cartilage Blended With Platelet-Rich Plasma and Wrapped With Poly (Lactic-Co-Glycolic) Acid Membrane
  144. Engineering the mechanical and biological properties of nanofibrous vascular grafts for in situ vascular tissue engineering
  145. Isolation and characterization of canine placenta-derived mesenchymal stromal cells for the treatment of neurological disorders in dogs
  146. microRNA-33a-5p increases radiosensitivity by inhibiting glycolysis in melanoma
  147. Manufacture and preparation of human placenta-derived mesenchymal stromal cells for local tissue delivery
  148. Discovery and Characterization of a Potent and Specific Peptide Ligand Targeting Endothelial Progenitor Cells and Endothelial Cells for Tissue Regeneration
  149. Highly Efficient Differentiation of Endothelial Cells from Pluripotent Stem Cells Requires the MAPK and the PI3K Pathways
  150. Sox10+ adult stem cells contribute to biomaterial encapsulation and microvascularization
  151. Tat PTD-Endostatin-RGD: A novel protein with anti-angiogenesis effect in retina via eye drops
  152. The beneficial effects of the herbal medicine Di-huang-yin-zi (DHYZ) on patients with ischemic stroke: A Randomized, Placebo controlled clinical study
  153. Age Does Matter: A Pilot Comparison of Placenta-Derived Stromal Cells for in utero Repair of Myelomeningocele Using a Lamb Model
  154. Placental Mesenchymal Stromal Cells Rescue Ambulation in Ovine Myelomeningocele
  155. Development of a Locomotor Rating Scale for Testing Motor Function in Sheep
  156. Placenta as a Source of Stem Cells for Regenerative Medicine
  157. Early gestation chorionic villi-derived stromal cells for fetal tissue engineering
  158. Neurorestoratologic Strategies and Mechanisms in the Nervous System
  159. A novel Bruch's membrane-mimetic electrospun substrate scaffold for human retinal pigment epithelium cells
  160. In utero repair of myelomeningocele with autologous amniotic membrane in the fetal lamb model
  161. Lentiviral vectors enveloped with rabies virus glycoprotein can be used as a novel retrograde tracer to assess nerve recovery in rat sciatic nerve injury models
  162. Human iPSC-Derived Neural Crest Stem Cells Promote Tendon Repair in a Rat Patellar Tendon Window Defect Model
  163. Synovial stem cells and their responses to the porosity of microfibrous scaffold
  164. Smooth Muscle Cells: To Be or Not To Be?
  165. Human induced pluripotent stem cell-derived neural crest stem cells integrate into the injured spinal cord in the fetal lamb model of myelomeningocele
  166. The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration
  167. Drug-eluting microfibrous patches for the local delivery of rolipram in spinal cord repair
  168. Femtosecond laser ablation enhances cell infiltration into three-dimensional electrospun scaffolds
  169. Derivation of Smooth Muscle Cells with Neural Crest Origin from Human Induced Pluripotent Stem Cells
  170. Differentiation of multipotent vascular stem cells contributes to vascular diseases
  171. Prenatal repair of myelomeningocele with aligned nanofibrous scaffolds—a pilot study in sheep
  172. Uniaxial Mechanical Strain Modulates the Differentiation of Neural Crest Stem Cells into Smooth Muscle Lineage on Micropatterned Surfaces
  173. Effects of Fluid Shear Stress on a Distinct Population of Vascular Smooth Muscle Cells
  174. Induced pluripotent stem cells for neural tissue engineering
  175. Engineering Bi-Layer Nanofibrous Conduits for Peripheral Nerve Regeneration
  176. Chitosan/silk fibroin-based tissue-engineered graft seeded with adipose-derived stem cells enhances nerve regeneration in a rat model
  177. The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-β
  178. Schwann-like cell differentiation of rat adipose-derived stem cells by indirect co-culture with Schwann cells in vitro
  179. The effect of topology of chitosan biomaterials on the differentiation and proliferation of neural stem cells
  180. In Vitro Regulation of Neural Differentiation and Axon Growth by Growth Factors and Bioactive Nanofibers
  181. Nanofibrous Patches for Spinal Cord Regeneration
  182. Transforming Growth Factor-β and Notch Signaling Mediate Stem Cell Differentiation into Smooth Muscle Cells
  183. An improved method for isolating Schwann cells from postnatal rat sciatic nerves
  184. The behavior of MC3T3-E1 cells on chitosan/poly-L-lysine composite films: Effect of nanotopography, surface chemistry, and wettability
  185. Surface Properties of Chitosan Films Modified with Polycations and Their Effects on the Behavior of PC12 Cells
  186. The Association of GSK3β with E2F1 Facilitates Nerve Growth Factor-induced Neural Cell Differentiation
  187. LEF-1 activates the transcription of E2F1
  188. Physical properties and biocompatibility of a porous chitosan-based fiber-reinforced conduit for nerve regeneration
  189. Preparation and Characterization of a Multilayer Biomimetic Scaffold for Bone Tissue Engineering
  190. Combined transplantation of neural stem cells and olfactory ensheathing cells for the repair of spinal cord injuries
  191. Erratum: Protective effects of extract of Ginkgo biloba (EGb 761) on nerve cells after spinal cord injury in rats
  192. Encapsulation of Drug Reservoirs in Fibers by Emulsion Electrospinning:  Morphology Characterization and Preliminary Release Assessment
  193. Protective effects of extract of Ginkgo biloba (EGb 761) on nerve cells after spinal cord injury in rats
  194. A sandwich tubular scaffold derived from chitosan for blood vessel tissue engineering
  195. Manufacture of multimicrotubule chitosan nerve conduits with novel molds and characterizationin vitro
  196. Porous chitosan tubular scaffolds with knitted outer wall and controllable inner structure for nerve tissue engineering
  197. Novel biodegradable films and scaffolds of chitosan blended with poly(3-hydroxybutyrate)